DECEMBER 16, 2016 TORONTO, ONTARIO — (Marketwired) — 12/16/16 — Supreme Pharmaceuticals Inc. (“Supreme” or the “Company“) (CSE:SL)(CSE:SL.CN) announces that at the annual general meeting of its shareholders (the “Meeting“) held in Toronto, Ontario on December 16, 2016, the shareholders approved the election of Mr. Chuck Rifici as a director of the Company. Mr. Rifici joins […]
DECEMBER 13, 2016 TORONTO, ONTARIO — (Marketwired) — 12/13/16 — Supreme Pharmaceuticals Inc. (“Supreme” or the “Company“) (CSE:SL) is pleased to announce the closing of its $50 million bought deal private placement (the “Brokered Offering“) and concurrent $5 million non-brokered private placement (together with the Brokered Offering, the “Offering“) for aggregate gross proceeds of $55 million. […]
NOVEMBER 17, 2016 TORONTO, ONTARIO –(Marketwired – Nov. 17, 2016 ) – NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES Supreme Pharmaceuticals Inc. (the “Company”) (CSE:SL)(CSE:SL.CN) is pleased to announce its intention to complete a non-brokered private placement (the “Non-Brokered Offering”) of up to $5 million of convertible debenture units on […]
NOVEMBER 14, 2016 Toronto, ON – November 14, 2016 – Supreme Pharmaceuticals Inc. (the “Company”) (CSE: SL) announced today that it has entered into an agreement with Canaccord Genuity Corp. on behalf of a syndicate of underwriters (the “Underwriters”) pursuant to which the Underwriters have agreed to purchase, on a bought deal, private placement basis, $40,000,000 aggregate principal amount of […]
NOVEMBER 15, 2016 Toronto, ON – November 15, 2016 – Supreme Pharmaceuticals Inc. (the “Company”) (CSE: SL) announced today that it has entered into a revised agreement with Canaccord Genuity Corp. on behalf of a syndicate of underwriters (the “Underwriters”) to increase the size of its previously announced bought deal, private placement of convertible debenture […]
OCTOBER 27, 2016 TORONTO, ONTARIO — (Marketwired) — 10/27/16 — Supreme Pharmaceuticals Inc. (the “Company” or “Supreme”) (CSE:SL)(CSE:SL.CN)(OTC PINK:SPRWF) wishes to clarify that, as a result of changes Health Canada made to its website today, Supreme’s operating subsidiary, AMMCan, was mistakenly shown as having been approved for the sale of dried marihuana. Supreme notified IIROC upon […]
SEPTEMBER 14, 2016 TORONTO, ONTARIO — (Marketwired) — 09/14/16 — Supreme Pharmaceuticals Inc. (the “Company” or “Supreme”) (CSE:SL)(OTC PINK:SPRWF) has issued 130,000 stock options (each an ” Option “) to a consultant of the Company. Each Option has an exercise price of $0.77 and is exercisable at any time prior to September 14 th , 2021, subject to the terms […]
AUGUST 30, 2016 TORONTO, ONTARIO — (Marketwired) — 08/30/16 — Supreme Pharmaceuticals Inc. (the “Company” or “Supreme”) (CSE:SL)(OTC PINK:SPRWF) is pleased to announce it has closed the third tranche of its previously announced non-brokered private placement (the “Financing“) for proceeds of $10,610,625 and aggregate proceeds from three tranches of $14,949,755. Pursuant to the Financing, the Company […]
AUGUST 08, 2016 TORONTO, ONTARIO — (Marketwired) — 08/08/16 — Supreme Pharmaceuticals Inc. (the “Company”) (CSE:SL)(OTC PINK:SPRWF) is pleased to announce that it has closed a $4,000,000 mortgage (the “Mortgage“) with a private lender with respect of its wholly owned subsidiary, 8528934 Canada Ltd. (“7 ACRES“) and the 7 ACRES’ Hybrid Greenhouse in Kincardine, Ontario. The […]
JULY 15, 2016 TORONTO, ONTARIO — (Marketwired) — 07/15/16 — Supreme Pharmaceuticals Inc. (the “Company” or “Supreme”) (CSE:SL)(OTC PINK:SPRWF) is pleased to announce it has closed the second tranche of its previously announced non-brokered private placement (the “Financing“) for proceeds of $723,250 and aggregate proceeds from both tranches of $4,339,130. Upon closing, the company issued 1,808,125 units […]